<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Cardiothorac Surg</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Cardiothorac Surg</journal-id><journal-id journal-id-type="publisher-id">ejcts</journal-id><journal-title-group><journal-title>European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery</journal-title></journal-title-group><issn pub-type="ppub">1010-7940</issn><issn pub-type="epub">1873-734X</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28444178</article-id><article-id pub-id-type="pmc">5848808</article-id><article-id pub-id-type="doi">10.1093/ejcts/ezx087</article-id><article-id pub-id-type="publisher-id">ezx087</article-id><article-categories><subj-group subj-group-type="heading"><subject>Myocardial Revascularization</subject></subj-group></article-categories><title-group><article-title>Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results from a multicentre randomized controlled trial: the SCAT trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rogers</surname><given-names>Chris A.</given-names></name><xref ref-type="aff" rid="ezx087-aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Capoun</surname><given-names>Radek</given-names></name><xref ref-type="aff" rid="ezx087-aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Lauren J.</given-names></name><xref ref-type="aff" rid="ezx087-aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Taylor</surname><given-names>Jodi</given-names></name><xref ref-type="aff" rid="ezx087-aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>Anil</given-names></name><xref ref-type="aff" rid="ezx087-aff3">c</xref></contrib><contrib contrib-type="author"><name><surname>Angelini</surname><given-names>Gianni D.</given-names></name><xref ref-type="aff" rid="ezx087-aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Narayan</surname><given-names>Pradeep</given-names></name><xref ref-type="aff" rid="ezx087-aff4">d</xref></contrib><contrib contrib-type="author"><name><surname>Suleiman</surname><given-names>M-Saadeh</given-names></name><xref ref-type="aff" rid="ezx087-aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Sarkar</surname><given-names>Kunal</given-names></name><xref ref-type="aff" rid="ezx087-aff4">d</xref></contrib><contrib contrib-type="author"><name><surname>Ascione</surname><given-names>Raimondo</given-names></name><xref ref-type="aff" rid="ezx087-aff2">b</xref><xref ref-type="corresp" rid="ezx087-cor1"/><!--<email>r.ascione@bristol.ac.uk</email>--></contrib></contrib-group><aff id="ezx087-aff1">
<label>a</label>Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK</aff><aff id="ezx087-aff2">
<label>b</label>Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, UK</aff><aff id="ezx087-aff3">
<label>c</label>SAL Hospital and Medical Institute, Ahmedabad, India</aff><aff id="ezx087-aff4">
<label>d</label>Rabindranath Tagore International Institute of Cardiac Sciences (RTIICS), Kolkata, India</aff><author-notes><corresp id="ezx087-cor1"><label>*</label>Corresponding author. Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Queens Building, Level 7, Bristol Royal Infirmary, Bristol BS2 8HW, UK. Tel: +44-117-3423286; e-mail: <email>r.ascione@bristol.ac.uk</email> (R. Ascione).</corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub" iso-8601-date="2017-04-24"><day>24</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>4</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><!-- oupReleaseDelayRemoved from OA Article (10.1093/ejcts/ezx087ezx087MYOCARDIAL REVASCULARIZATIONEACTS/23EACTS/31EACTS/35Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results from a multicentre randomized controlled trial: the SCAT trialRogersChris A.CapounRadekScottLauren J.TaylorJodiJainAnilAngeliniGianni D.NarayanPradeepSuleimanM-SaadehSarkarKunalAscioneRaimondor.ascione@bristol.ac.uk
        aClinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK
        bBristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, UK
        cSAL Hospital and Medical Institute, Ahmedabad, India
        dRabindranath Tagore International Institute of Cardiac Sciences (RTIICS), Kolkata, India*Corresponding author. Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Queens Building, Level 7, Bristol Royal Infirmary, Bristol BS2 8HW, UK. Tel: +44-117-3423286; e-mail: r.ascione@bristol.ac.uk (R. Ascione).0820170108201724042017522288296Supplementary Data121020163001201726022017&#x000a9; The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.2017This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Abstract
          OBJECTIVES: Combined coronary artery bypass grafting and valve surgery requires a prolonged period of cardioplegic arrest (CA) predisposing to myocardial injury and postoperative cardiac-specific complications. The aim of this trial was to reduce the CA time in patients undergoing combined coronary artery bypass grafting and valve surgery and assess if this was associated with less myocardial injury and related complications.
          METHODS: Participants were randomized to (i) coronary artery bypass grafting performed on the beating heart with cardiopulmonary bypass support followed by CA for the valve procedure (hybrid) or (ii) both procedures under CA (conventional). To assess complications related to myocardial injury, we used the composite of death, myocardial infarction, arrhythmia, need for pacing or inotropes for&#x02009;>12&#x02009;h. To assess myocardial injury, we used serial plasma troponin T and markers of metabolic stress in myocardial biopsies.
          RESULTS: Hundred and sixty patients (80 hybrid and 80 conventional) were randomized. Mean age was 66.5 years and 74% were male. Valve procedures included aortic (61.8%) and mitral (33.1%) alone or in combination (5.1%). CA time was 16% lower in the hybrid group [median 98 vs 89&#x02009;min, geometric mean ratio (GMR) 0.84, 95% confidence interval (CI) 0.77&#x02013;0.93, P&#x02009;=&#x02009;0.0004]. Complications related to myocardial injury occurred in 131/160 patients (64/80 conventional, 67/80 hybrid), odds ratio 1.24, 95% CI 0.54&#x02013;2.86, P&#x02009;=&#x02009;0.61. Release of troponin T was similar between groups (GMR 1.04, 95% CI 0.87&#x02013;1.24, P&#x02009;=&#x02009;0.68). Adenosine monophosphate was 28% lower in the hybrid group (GMR 0.72, 95% CI 0.51&#x02013;1.02, P&#x02009;=&#x02009;0.056).
          CONCLUSIONS: The hybrid procedure reduced the CA time but myocardial injury outcomes were not superior to conventional approach.
          TRIAL REGISTRATION: ISRCTN65770930.Myocardial protectionBeating heart coronary surgeryCardioplegic arrestValve surgeryNational Institutes of Health10.13039/100000002) --><volume>52</volume><issue>2</issue><fpage>288</fpage><lpage>296</lpage><history><date date-type="received"><day>12</day><month>10</month><year>2016</year></date><date date-type="rev-recd"><day>30</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>2</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.</copyright-statement><copyright-year>2017</copyright-year><license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="ezx087.pdf"/><abstract><title>Abstract</title><p>
<bold>OBJECTIVES:</bold> Combined coronary artery bypass grafting and valve surgery requires a prolonged period of cardioplegic arrest (CA) predisposing to myocardial injury and postoperative cardiac-specific complications. The aim of this trial was to reduce the CA time in patients undergoing combined coronary artery bypass grafting and valve surgery and assess if this was associated with less myocardial injury and related complications.</p><p>
<bold>METHODS:</bold> Participants were randomized to (i) coronary artery bypass grafting performed on the beating heart with cardiopulmonary bypass support followed by CA for the valve procedure (hybrid) or (ii) both procedures under CA (conventional). To assess complications related to myocardial injury, we used the composite of death, myocardial infarction, arrhythmia, need for pacing or inotropes for&#x02009;&#x0003e;12&#x02009;h. To assess myocardial injury, we used serial plasma troponin T and markers of metabolic stress in myocardial biopsies.</p><p>
<bold>RESULTS:</bold> Hundred and sixty patients (80 hybrid and 80 conventional) were randomized. Mean age was 66.5 years and 74% were male. Valve procedures included aortic (61.8%) and mitral (33.1%) alone or in combination (5.1%). CA time was 16% lower in the hybrid group [median 98 vs 89&#x02009;min, geometric mean ratio (GMR) 0.84, 95% confidence interval (CI) 0.77&#x02013;0.93, <italic>P</italic>&#x02009;=&#x02009;0.0004]. Complications related to myocardial injury occurred in 131/160 patients (64/80 conventional, 67/80 hybrid), odds ratio 1.24, 95% CI 0.54&#x02013;2.86, <italic>P</italic>&#x02009;=&#x02009;0.61. Release of troponin T was similar between groups (GMR 1.04, 95% CI 0.87&#x02013;1.24, <italic>P</italic>&#x02009;=&#x02009;0.68). Adenosine monophosphate was 28% lower in the hybrid group (GMR 0.72, 95% CI 0.51&#x02013;1.02, <italic>P</italic>&#x02009;=&#x02009;0.056).</p><p>
<bold>CONCLUSIONS:</bold> The hybrid procedure reduced the CA time but myocardial injury outcomes were not superior to conventional approach.</p><p>
<bold>TRIAL REGISTRATION:</bold> ISRCTN65770930.</p></abstract><kwd-group kwd-group-type="author"><kwd>Myocardial protection</kwd><kwd>Beating heart coronary surgery</kwd><kwd>Cardioplegic arrest</kwd><kwd>Valve surgery</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">National Institutes of Health</named-content><named-content content-type="funder-identifier">10.13039/100000002</named-content></funding-source></award-group></funding-group><counts><page-count count="9"/></counts></article-meta></front><body><sec><title>INTRODUCTION</title><p>The number of patients requiring surgery to treat concomitant valve and coronary disease is rapidly increasing [<xref rid="ezx087-B1" ref-type="bibr">1&#x02013;3</xref>]. Between 2001 and 2010, the proportion of patients requiring valve procedures, combined valve and coronary artery bypass grafting and other procedures increased from 29% to 50% [<xref rid="ezx087-B2" ref-type="bibr">2</xref>, <xref rid="ezx087-B3" ref-type="bibr">3</xref>]. Combined valve and coronary artery bypass grafting surgery leads to marked myocardial injury and is associated with in-hospital mortality twice that of valve surgery alone, and 4 times that of coronary artery bypass grafting alone [<xref rid="ezx087-B4" ref-type="bibr">4&#x02013;6</xref>]. Determinants of myocardial injury include prolonged cardioplegic arrest (CA) and cardiopulmonary bypass (CPB) times, and concomitant ischaemic and hypertrophic disease. Cardiac-specific complications associated with myocardial injury includes death, myocardial infarction (MI), arrhythmias, need for pacing, need for inotropes and low-cardiac output syndrome [<xref rid="ezx087-B7" ref-type="bibr">7&#x02013;15</xref>]. The presence of left ventricular hypertrophy secondary to aortic stenosis increases susceptibility to ischaemia with accelerated loss of high-energy nucleotides and greater accumulation of lactate [<xref rid="ezx087-B11" ref-type="bibr">11&#x02013;16</xref>]. Myocardial injury in these patients is exacerbated by the concomitant presence of coronary disease, left ventricular hypertrophy and prolonged CA time [<xref rid="ezx087-B7" ref-type="bibr">7</xref>, <xref rid="ezx087-B16" ref-type="bibr">16</xref>, <xref rid="ezx087-B17" ref-type="bibr">17</xref>]. In a small pilot study in 40 patients (unpublished data) with coronary and valve disease, we used our expertize in beating heart coronary surgery [<xref rid="ezx087-B17" ref-type="bibr">17&#x02013;21</xref>] and our previous experience in on-pump beating heart coronary surgery [<xref rid="ezx087-B22" ref-type="bibr">22</xref>] to explore the feasibility of shortening CA time with a view to reduce myocardial injury. We performed coronary surgery first with CPB support on the beating heart, followed by CA for the valve procedure (hybrid procedure) and observed a shorter CA time and a trend to less MI, arrhythmias, need for pacing or for inotropes. The aim of this trial was to ascertain the safety and efficacy of the hybrid procedure in reducing myocardial injury as assessed by a composite of related postoperative cardiac-specific complications and by release of troponin T and markers of myocardial oxidative stress in biopsies.</p></sec><sec><title>MATERIALS AND METHODS</title><sec><title>Study design</title><p>A multicentre parallel-group randomized controlled trial (ISRCTN 65770930).</p></sec><sec><title>Participants</title><p>Adults aged between 16 and 85 years with severe coronary disease and aortic and/or mitral valve disease (confirmed by transthoracic echocardiography and angiogram) were eligible. History of diabetes, malignancy, debilitating neurological disease, ongoing sepsis or endocarditis, or preoperative creatinine&#x02009;&#x0003e;160 &#x000b5;m/l, or need for emergency or salvage procedures were exclusion criteria.</p></sec><sec><title>Study settings</title><p>The study was conducted at the Bristol Heart Institute, Bristol (UK), Rabindranath Tagore International Institute, Kolkata and the SAL Hospital, Ahmedabad (India) by surgeons willing to operate using either methods. The University Hospital Bristol NHS Foundation Trust sponsored the trial in the UK. In India, the study was sponsored by the 2 host institutions. The trial was approved by the Southmead Research Ethics Committee (ref. CS/2006/2267) in the UK and by local hospital Ethics Committees in India.</p></sec><sec><title>Interventions</title><p>Participants were randomly allocated to either (i) <italic>conventional surgery</italic> with both coronary and valve surgery being performed during CPB and CA; or (ii) <italic>hybrid surgery</italic> with coronary surgery carried out first on the beating heart with CPB support, followed by CA to undertake valve surgery.</p></sec><sec><title>Surgical methods</title><p>Surgery, anaesthesia and postoperative management were according to standardized protocols [<xref rid="ezx087-B7" ref-type="bibr">7</xref>, <xref rid="ezx087-B16" ref-type="bibr">16</xref>]. Moderate hypothermic CPB (32&#x000b0;C) was used. For the hybrid group on-pump beating heart coronary grafting was carried out at CPB mean arterial pressure around 75&#x02009;mmHg to optimize myocardial perfusion. Mode of cardiac stabilization and coronary grafting was according to established routine at each centre. For both groups, CA was achieved with cold (4&#x02013;6&#x000b0;C) blood cardioplegia: patient&#x02019;s blood and St Thomas&#x02019; I cardioplegic solution (4:1) with extra K<sup>+</sup> and Mg<sup>2+</sup> added. Final K<sup>+</sup> and Mg<sup>2+</sup> concentrations were 20 and 4&#x02009;mM, respectively. Antegrade cardioplegia was delivered under pressure (100&#x02013;150&#x02009;mmHg) directly into the coronary ostia or the aortic root, while retrograde cardioplegia was delivered under pressure (20&#x02013;30&#x02009;mmHg) directly into the coronary sinus at 20&#x02009;min intervals. Following surgery, patients were admitted to the cardiac intensive care unit and managed by blind intensivists. Decisions regarding need for inotropic support, pacing and mode of ventilation were based on established routine clinical care [<xref rid="ezx087-B7" ref-type="bibr">7</xref>, <xref rid="ezx087-B18" ref-type="bibr">18&#x02013;22</xref>]. Heart rate, rhythm and ST changes were continuously monitored during the first 72&#x02009;h postoperatively. A twelve-lead electrocardiogram (ECG) was performed prior to surgery, at 4&#x02009;h postoperatively, and then daily for 5 days.</p></sec><sec><title>Outcome measures</title><sec><title>Primary outcome: composite of complications related to myocardial injury</title><p>This included in-hospital death (in-hospital or 30-day death), postoperative MI (new Q waves &#x02265;0.04&#x02009;cm or a reduction in R waves of &#x0003e;25% in at least 2 leads), arrhythmia (supraventricular tachycardia/atrial fibrillation or ventricular tachycardia/ventricular fibrillation, need for cardiac pacing &#x0003e;12&#x02009;h, need for inotropic support &#x0003e;12&#x02009;h (dobutamine &#x02265;3 &#x000b5;g/kg/min, and/or adrenaline &#x02265;1 &#x000b5;g/kg/min, and/or dopamine &#x02265;5 &#x000b5;g/kg/min or any dose of enoximone).</p></sec><sec><title>Secondary outcomes: direct myocardial injury</title><p>This was assessed by measuring serial plasma release of cardiac troponin T (cTnT) at baseline (prior to surgery), and at 1, 4, 12, 24, 48 and 72&#x02009;h postoperatively. In addition, markers of metabolic stress were measured in a consecutive series of patients in Bristol in myocardial biopsies collected from the apex of the left ventricle using a Trucut biopsy needle 5&#x02009;min following CPB institution, (control biopsy), and 10&#x02009;min after releasing the cross-clamp (reperfusion biopsy). Specimens were immediately frozen in liquid nitrogen and stored until processing [<xref rid="ezx087-B7" ref-type="bibr">7</xref>].</p></sec></sec><sec><title>Other clinical outcome</title><p>We recorded duration of CPB and CA time, low-cardiac output (defined as need for adrenaline, dobutamine, enoximone or dopamine (dose&#x02009;&#x02265;&#x02009;5ug/kg/min) or intra-aortic balloon pump (IABP) for&#x02009;&#x0003e;3&#x02009;h), blood loss, transfusion requirement, intubation time, pulmonary, infective, renal, gastrointestinal (GI) and neurological complications, cardiac intensive care unit and hospital stay.</p></sec><sec><title>Sample size</title><p>The calculation was based on the incidence of cardiac complications related to myocardial injury observed is the pilot study including death, MI, arrhythmias, need for pacing and need for inotropic support for&#x02009;&#x0003e;12&#x02009;h. The pilot showed that 50% of patients in the hybrid group experienced this composite compared to 80% of patients in the conventional group i.e. a 30% reduction. Based on this outcome, a trial of 120 patients, 60 per group, would have been needed to detect the observed 30% reduction in the proposed composite, from 80% to 50%, with 90% power, assuming a 5% level of statistical significance and a two-sided test. We elected for a larger sample size of 160 patients, 80 per group. In addition, we elected to assess myocardial injury directly using (i) serial plasma release of troponin T in 140 patients, 70 per group; and (ii) serial markers of myocardial oxidative stress in myocardial biopsies in 40 consecutive patients in Bristol, 20 per group, based on the outcome of previous similar work, e.g. [<xref rid="ezx087-B7" ref-type="bibr">7</xref>, <xref rid="ezx087-B17" ref-type="bibr">17</xref>].</p></sec><sec><title>Randomization and blinding</title><p>Patients were assigned immediately prior to surgery to the conventional or hybrid group in a 1:1 ratio using cohort minimization to achieve balance across surgeons (and therefore centres) and type of valve surgery (aortic, mitral or both). Concealed random allocations were generated by computer once the relevant baseline data (information to identify the patient, the surgeon and the type of surgery) had been entered into the system. Intensive care unit consultants and nurses as well as the study participants were masked to the study allocation.</p></sec><sec><title>Statistical methods</title><p>Analyses were performed on an intention-to-treat basis and in keeping with a pre-specified statistical analysis plan. Continuous data are summarized as mean standard deviation or median [interquartile range (IQR)] if distributions are skewed. Categorical data are summarized as number (percentage). Outcomes were compared using logistic (binary variables), Cox proportional hazards (time to event variables for secondary outcomes intubation time, intensive care length of stay and hospital stay), or linear mixed model (continuous variables measured at multiple time points) regression, with conventional surgery as the reference group. Model validity was checked using standard methods; if a model fitted poorly, transformations were explored. Outcomes analysed on a logarithmic scale were transformed back to the original scale after analysis and results presented as geometric mean ratios (GMR). See the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref> for further details. All outcomes were adjusted for the stratification variables including: surgical centre, and type of valve surgery. Likelihood ratio tests were used to determine statistical significance, and two-tailed <italic>P</italic>-values&#x02009;&#x0003c;&#x02009;0.05 were considered statistically significant. A subgroup analysis comparing centre-specific cTnT concentrations was prespecified in the statistical analysis plan. Subgroups were compared, by adding an allocation by centre interaction term into the model. Subgroup-specific effects are reported if the interaction term was statistically significant at the 10% level. All analyses were performed in SAS version 9.3 (SAS Institute Inc, Cary, NC, USA) and Stata version 13.0 (StataCorp LP, College Station, TX, USA).</p></sec></sec><sec><title>RESULTS</title><sec><title>Patient recruitment</title><p>Between 19 March 2008 and 01 July 2012, 165 patients gave written consent and were randomized; 5 were withdrawn prior to surgery, leaving 160 patients who received surgery and were included in analysis population (80 randomized to conventional surgery and 80 to hybrid surgery, Fig. <xref ref-type="fig" rid="ezx087-F1">1</xref>). In total, 81 patients were recruited in Bristol, 60 in Kolkata and 19 in Ahmedabad. There were 5 protocol deviations. Serious adverse events were also captured for UK patients (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Tables SE1&#x02013;SE3).</p><fig id="ezx087-F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow of participants through the trial. Notes: <sup>1</sup>Reasons for exclusion are only available for the Bristol site. <sup>2</sup>Some patients were ineligible for more than one reason.</p></caption><graphic xlink:href="ezx087f1"/></fig></sec><sec><title>Baseline characteristics</title><p>Baseline characteristics were similar between groups (Table <xref ref-type="table" rid="ezx087-T1">1</xref>). The mean age was 66.5 years and 74% of patients were male. The median additive EuroSCORE was 3 for both groups. Intraoperative details are shown in Table <xref ref-type="table" rid="ezx087-T2">2</xref>. Overall, 97 patients had an aortic valve replacement, 52 had a mitral valve replacement or repair and 8 had both (Table <xref ref-type="table" rid="ezx087-T2">2</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Table SE4). All patients received cold blood cardioplegia.
<table-wrap id="ezx087-T1" orientation="portrait" position="float"><label>Table 1:</label><caption><p>Baseline characteristics</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1">Conventional (<italic>n</italic> = 80)<hr/></th><th colspan="2" rowspan="1">Hybrid (<italic>n</italic> = 80)<hr/></th><th colspan="2" rowspan="1">Overall (<italic>n</italic> = 160)<hr/></th></tr><tr><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td colspan="7" rowspan="1">Demographics</td></tr><tr><td rowspan="1" colspan="1">Age (years) (mean, SD)</td><td rowspan="1" colspan="1">66.7</td><td rowspan="1" colspan="1">10.12</td><td rowspan="1" colspan="1">66.3</td><td rowspan="1" colspan="1">9.67</td><td rowspan="1" colspan="1">66.5</td><td rowspan="1" colspan="1">9.87</td></tr><tr><td rowspan="1" colspan="1">Male gender</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">75.0</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">73.8</td><td rowspan="1" colspan="1">119</td><td rowspan="1" colspan="1">74.4</td></tr><tr><td rowspan="1" colspan="1">BMI (mean, SD)</td><td rowspan="1" colspan="1">25.5</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">25.7</td><td rowspan="1" colspan="1">4.97</td><td rowspan="1" colspan="1">25.6</td><td rowspan="1" colspan="1">5.26</td></tr><tr><td colspan="7" rowspan="1">Cardiac history</td></tr><tr><td colspan="7" rowspan="1">NYHA class</td></tr><tr><td rowspan="1" colspan="1">&#x02003;I/Asymptomatic</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">12.5</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">5.0</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">8.8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;II</td><td rowspan="1" colspan="1">45</td><td rowspan="1" colspan="1">56.3</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">61.3</td><td rowspan="1" colspan="1">94</td><td rowspan="1" colspan="1">58.8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;III</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">27.5</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">31.3</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">29.4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;IV</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">3.8</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">3.1</td></tr><tr><td colspan="7" rowspan="1">Angina class</td></tr><tr><td rowspan="1" colspan="1">&#x02003;No angina</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">28.8</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">25.0</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">26.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;I</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">10.0</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">17.5</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">13.8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;II</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">45.0</td><td rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1">48.8</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">46.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;III</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">13.8</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">7.5</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">10.6</td></tr><tr><td rowspan="1" colspan="1">&#x02003;IV</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1.9</td></tr><tr><td rowspan="1" colspan="1">Previous MI</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">5.0</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">5.6</td></tr><tr><td rowspan="1" colspan="1">Congestive cardiac failure</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">8.8</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">8.8</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">8.8</td></tr><tr><td colspan="7" rowspan="1">Heart rhythm</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Sinus rhythm</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">78.8</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">83.5</td><td rowspan="1" colspan="1">129</td><td rowspan="1" colspan="1">81.1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Sinus rhythm and heart block</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">7.6</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">6.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;AF/flutter</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">12.5</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">8.9</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">10.7</td></tr><tr><td rowspan="1" colspan="1">&#x02003;AF/flutter and heart block</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1.3</td></tr><tr><td rowspan="1" colspan="1">Permanent pacemaker</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1.3</td></tr><tr><td rowspan="1" colspan="1">MI&#x02009;&#x0003c;90 days ago</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">8.8</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">7.5</td></tr><tr><td colspan="7" rowspan="1">Baseline LV function</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Good</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">75.0</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">69.6</td><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">72.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Moderate</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">21.3</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">26.6</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">23.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Poor</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">3.8</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">3.8</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">3.77</td></tr><tr><td colspan="7" rowspan="1">Coronary disease</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Single</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">38.8</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">35.4</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">37.1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Double</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">36.3</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">36.7</td><td rowspan="1" colspan="1">58</td><td rowspan="1" colspan="1">36.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Triple</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">25.0</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">27.8</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">26.4</td></tr><tr><td rowspan="1" colspan="1">Left main stem disease</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">7.5</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">8.8</td></tr><tr><td colspan="7" rowspan="1">Other medical history</td></tr><tr><td rowspan="1" colspan="1">Peptic ulceration</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">4.4</td></tr><tr><td rowspan="1" colspan="1">Renal failure</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">5.0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">3.8</td></tr><tr><td rowspan="1" colspan="1">Peripheral vascular disease</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">12.5</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">9.4</td></tr><tr><td rowspan="1" colspan="1">Severe asthma</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">2.5</td></tr><tr><td rowspan="1" colspan="1">Other medical conditions</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">25.0</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">21.3</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">23.1</td></tr><tr><td rowspan="1" colspan="1">EuroSCORE</td><td rowspan="1" colspan="1">3.0</td><td rowspan="1" colspan="1">(2.0, 5.0)</td><td rowspan="1" colspan="1">3.0</td><td rowspan="1" colspan="1">(1.5, 5.0)</td><td rowspan="1" colspan="1">3.0</td><td rowspan="1" colspan="1">(2.0, 5.0)</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>Missing data (conventional, hybrid): BMI, Warfarin, Other drugs: 1 (1, 0). Heart rhythm, IV Nitrates: 1 (0, 1).</p></fn><fn id="tblfn2"><p>BMI: body mass index; MI: myocardial infarction; AF: atrial fibrillation; LV: left ventricular; IV intravenous; SD: standard deviation; NYHA: New York Heart Association.</p></fn></table-wrap-foot></table-wrap><table-wrap id="ezx087-T2" orientation="portrait" position="float"><label>Table 2:</label><caption><p>Intraoperative details</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1">Conventional (<italic>n</italic> = 80)<hr/></th><th colspan="2" rowspan="1">Hybrid (<italic>n</italic> = 80)<hr/></th><th colspan="2" rowspan="1">Overall (<italic>n</italic> = 160)<hr/></th></tr><tr><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td colspan="7" rowspan="1">Valve details</td></tr><tr><td colspan="7" rowspan="1">Valve surgery type:</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Aortic valve</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">61.0</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">62.5</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">61.8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Repaired</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2.1</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Replaced</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">97.9</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">99.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Mitral valve</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">32.5</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">33.8</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">33.1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Repaired</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">48.0</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">51.9</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">50.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Replaced</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">52.0</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">48.1</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">50.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Both</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.5</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">3.8</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">5.1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Both repaired</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">33.3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">12.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Both replaced</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">80.0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">66.7</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">75.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Mitral repaired, aortic replaced</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">20.0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">12.5</td></tr><tr><td colspan="7" rowspan="1">Coronary details</td></tr><tr><td rowspan="1" colspan="1">No. of coronary grafts (median, IQR)</td><td rowspan="1" colspan="1">2.0</td><td rowspan="1" colspan="1">(1.0, 2.0)</td><td rowspan="1" colspan="1">2.0</td><td rowspan="1" colspan="1">(1.0, 2.0)</td><td rowspan="1" colspan="1">2.0</td><td rowspan="1" colspan="1">(1.0, 2.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;1</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">41.3</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">41.3</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">41.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;2</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">36.3</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">37.5</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">36.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;3</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">15.0</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">15.0</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">15.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;4</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">7.5</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">6.9</td></tr><tr><td rowspan="1" colspan="1">Other procedure<sup>a</sup></td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">7.5</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">6.9</td></tr></tbody></table><table-wrap-foot><fn id="tblfn3"><label>a</label><p>Two procedures of ablation of atrial fibrillation, 2 tricuspid valve repairs, 1 small left ventricular aneurysm repair, and 1 closure of patent foramen ovale in the conventional group; and 1 closure of patent foramen ovale, 1 aortic root enlargement, 1 removal of left atrial appendix with stapling due to thrombus, 1 ablation of atrial fibrillation and 1 patch closure of a healed ventricular septal defect in the hybrid group.</p></fn><fn id="tblfn4"><p>IQR: interquartile range.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Primary outcome: composite of complications related to myocardial injury</title><p>The number of patients experiencing the primary outcome was 64/80 (80.0%) in the conventional surgery group and 67/80 (83.8%) in the hybrid group [odds ratio (OR) 1.24, 95% confidence interval (CI) 0.54&#x02013;2.86, <italic>P</italic>&#x02009;=&#x02009;0.61; Fig. <xref ref-type="fig" rid="ezx087-F2">2</xref>]. In total, there were 16 in-hospital/30-day deaths (10%), 7 in the conventional group and 9 in the hybrid group (Table <xref ref-type="table" rid="ezx087-T3">3</xref>). Of these, 4/81 (4.9%) occurred in Bristol (2 in the conventional and 2 in the hybrid group) and 12/79 (15.2%) in India (5 in the conventional and 7 in the hybrid group). There was 1&#x02009;MI (1.3%) in the conventional group. Need for inotropic support &#x0003e;12&#x02009;h was 50.0% in the conventional group, 55.0% in the hybrid group, while the incidence of new arrhythmia was 46.3% in the conventional group, 32.5% in the hybrid group.</p><fig id="ezx087-F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Primary and secondary clinical outcomes. OR and 95% CI for the effect of hybrid versus conventional surgery on the primary and secondary outcomes. CICU: cardiac intensive care unit.</p></caption><graphic xlink:href="ezx087f2"/></fig><p>
<table-wrap id="ezx087-T3" orientation="portrait" position="float"><label>Table 3:</label><caption><p>Primary outcome: cardiac specific composite</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1">Conventional (<italic>n</italic> = 80)<hr/></th><th colspan="2" rowspan="1">Hybrid (<italic>n</italic> = 80)<hr/></th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">
<italic>P</italic>-value</th></tr><tr><th rowspan="1" colspan="1">
<italic>n</italic>
</th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1">
<italic>n</italic>
</th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td colspan="8" rowspan="1">Primary outcome</td></tr><tr><td rowspan="1" colspan="1">In-hospital/30-day death</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">8.8</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">11.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Postoperative MI</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Arrhythmia</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">46.3</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">45.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Cardiac pacing &#x0003e;12&#x02009;h</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">41.3</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">32.5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Postoperative inotropic support &#x0003e;12&#x02009;h<xref ref-type="table-fn" rid="tblfn6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">50.0</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">55.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Composite primary outcome</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">80.0</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">83.8</td><td rowspan="1" colspan="1">1.24 (0.54&#x02013;2.86)</td><td rowspan="1" colspan="1">0.612</td></tr></tbody></table><table-wrap-foot><fn id="tblfn5"><p>Missing data (conventional, hybrid): Post-op MI: 2 (1, 1).</p></fn><fn id="tblfn6"><label>a</label><p>Including dopamine<italic>&#x02009;</italic>&#x02265;5 &#x000b5;g/kg/min, dobutamine&#x02009;&#x02265;3 &#x000b5;g/kg/min, adrenaline&#x02009;&#x02265;1 &#x000b5;g/kg/min and any dose of enoximone.</p></fn><fn id="tblfn7"><p>MI: myocardial infarction; OR: odds ratio; CI: confidence interval.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec><title>Secondary outcome: direct myocardial injury</title><p>Cardiac TnT measurements were undertaken in Bristol and Kolkata in 138 patients. Release of cTnT was similar in the 2 groups at all the time points (treatment by time interaction <italic>P</italic>&#x02009;=&#x02009;0.20, overall estimate of difference between the 2 groups GMR 1.04, 95% CI 0.87&#x02013;1.24, <italic>P</italic>&#x02009;=&#x02009;0.68, Fig. <xref ref-type="fig" rid="ezx087-F3">3</xref>A, <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Table SE8). There was no difference in the effect of treatment on troponin between the UK and India participants (<italic>P</italic>&#x02009;=&#x02009;0.48), although higher levels of cTnT release were observed in India compared to Bristol (Fig. <xref ref-type="fig" rid="ezx087-F3">3</xref>B). For metabolic stress, levels of adenosine diphosphate and adenosine monophosphate measured in reperfusion biopsies in a subgroup of 36 patients in Bristol were lower compared to baseline in both the hybrid group with GMRs of 0.81 (95% CI 0.63&#x02013;1.05, <italic>P</italic>&#x02009;=&#x02009;0.099) and the conventional group 0.72 (95% CI 0.51&#x02013;1.02, <italic>P</italic>&#x02009;=&#x02009;0.056). There were no differences between the groups with respect to adenosine triphosphate (ATP), ATP/adenosine diphosphate, ATP/adenosine monophosphate with mean differences of &#x02212;0.21, 95% CI &#x02212;0.94 to 0.52, <italic>P</italic>&#x02009;=&#x02009;0.57; 0.03, 95% CI &#x02212;0.28 to 0.34, <italic>P</italic>&#x02009;=&#x02009;0.83 and 0.73, 95% CI &#x02212;0.45 to 1.91, <italic>P</italic>&#x02009;=&#x02009;0.21, respectively. Similarly, there was no difference for lactate (GMR 0.82, 95% CI 0.58&#x02013;1.16, <italic>P</italic>&#x02009;=&#x02009;0.24, Fig. <xref ref-type="fig" rid="ezx087-F4">4</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Table SE9).</p><fig id="ezx087-F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>(<bold>A</bold>) Overall troponin concentrations over time by treatment group. Geometric mean (ng/l) and 95% CI at all time points by group, and geometric mean ratio and 95% CI for the effect of hybrid versus conventional surgery on troponin concentration. (<bold>B</bold>) Troponin concentrations over time by treatment group and centre. Geometric mean and 95% CI at all time points by group and centre. Test for treatment by centre interaction, <italic>P</italic>&#x02009;=&#x02009;0.48. Pre-op: preoperative; Post-op: postoperative.</p></caption><graphic xlink:href="ezx087f3"/></fig><fig id="ezx087-F4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Myocardial metabolic stress outcomes. (<bold>A</bold>) Mean differences (MD) and 95% CI for the effect of hybrid versus conventional surgery on ATP, ATP/ADP and ATP/AMP (nmole/mg wet weight). (<bold>B</bold>) GMR and 95% CI for the effect of hybrid versus conventional surgery on ADP, AMP and Lactate (nmole/mg wet weight). ATP: adenosine triphosphate; ADP: adenosine diphosphate; AMP: adenosine monophosphate.</p></caption><graphic xlink:href="ezx087f4"/></fig></sec><sec><title>Operative details and other clinical outcomes</title><p>Operative details are shown in Table <xref ref-type="table" rid="ezx087-T4">4</xref>. Duration of CA was reduced from a median of 98&#x02009;min (IQR 79&#x02013;135) in the conventional group to 89&#x02009;min (IQR 63&#x02013;118) in the hybrid group and this was statistically significant (GMR 0.84, 95% CI 0.77&#x02013;0.93, <italic>P</italic>&#x02009;=&#x02009;0.0004). CPB time was 7% longer in the hybrid group (GMR 1.07, 95% CI 0.98&#x02013;1.16, <italic>P</italic>&#x02009;=&#x02009;0.12). Operation time was 4% longer in the hybrid group (<italic>P</italic>&#x02009;=&#x02009;0.2). Descriptive only key secondary clinical outcome including pulmonary, infective, renal and neurological complications are shown in Table <xref ref-type="table" rid="ezx087-T4">4</xref>. The incidence of stroke was 1.3% vs 2.6% in the conventional versus hybrid group respectively.
<table-wrap id="ezx087-T4" orientation="portrait" position="float"><label>Table 4:</label><caption><p>Secondary clinical outcome</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1">Conventional (<italic>n</italic> = 80)<hr/></th><th colspan="2" rowspan="1">Hybrid (<italic>n</italic> = 80)<hr/></th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr><tr><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"><italic>n</italic></th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td colspan="7" rowspan="1">Intraoperative outcome</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Operation time (median, IQR)</td><td rowspan="1" colspan="1">288</td><td rowspan="1" colspan="1">(220, 403)</td><td rowspan="1" colspan="1">300</td><td rowspan="1" colspan="1">(245, 405)</td><td rowspan="1" colspan="1">GMR=1.18 (0.94&#x02013;1.21)</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td rowspan="1" colspan="1">&#x02003;CPB time (min) (median, IQR)</td><td rowspan="1" colspan="1">142</td><td rowspan="1" colspan="1">(105, 195)</td><td rowspan="1" colspan="1">153</td><td rowspan="1" colspan="1">(115, 233)</td><td rowspan="1" colspan="1">GMR=1.07 (0.98&#x02013;1.16)</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">&#x02003;CA time (min) (median, IQR)</td><td rowspan="1" colspan="1">98</td><td rowspan="1" colspan="1">(79, 135)</td><td rowspan="1" colspan="1">89</td><td rowspan="1" colspan="1">(63, 118)</td><td rowspan="1" colspan="1">GMR=0.84 (0.77&#x02013;0.93)</td><td rowspan="1" colspan="1">0.0004</td></tr><tr><td colspan="7" rowspan="1">Other postoperative outcome</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Reintubation</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">5.2</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">7.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Tracheostomy</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">5.2</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Septicaemia</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.6</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Sternotomy infection</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Renal failure with dialysis</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">5.2</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">7.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Stroke</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Transient ischaemic attack</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tblfn8"><p>OR: odds ratio; CI: confidence interval; IQR: interquartile range; GMR: geometric mean ratio; CPB: cardiopulmonary bypass; CA: cardioplegic arrest.</p></fn></table-wrap-foot></table-wrap></p><p>There was no difference between groups for low-cardiac output (29/80, 36.3% vs 26/80, 32.5%, OR 0.84, 95% CI 0.39&#x02013;1.79, <italic>P</italic>&#x02009;=&#x02009;0.65), transfusion requirement (66/80, 82.5% vs 65/80, 82.3%, OR 0.87, 95% CI 0.35&#x02013;2.18, <italic>P</italic>&#x02009;=&#x02009;0.77), blood loss (median 363 vs 400&#x02009;ml, GMR 0.96, 95% CI 0.78&#x02013;1.18, <italic>P</italic>&#x02009;=&#x02009;0.70), combined non-cardiac subsystem organ complication (44/50, 55.0% vs 51/50, 63.8%, OR 1.49, 95% CI 0.72&#x02013;3.08, <italic>P</italic>&#x02009;=&#x02009;0.28), serious adverse events, intubation time, cardiac intensive care unit length of stay and hospital stay being also similar between the 2 groups (Fig. <xref ref-type="fig" rid="ezx087-F2">2</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Tables SE5&#x02013;SE7, Fig. SE1).</p></sec></sec><sec><title>DISCUSSION</title><p>This is the first trial to evaluate the hybrid procedure in patients undergoing combined coronary and valve surgery. The incidence of the composite primary endpoint was 80% in the conventional group of this trial. This confirms methodologically the excellent predictive value of our preliminary pilot study, in which the frequency of the same composite was also 80%. However for the hybrid group a 50% composite event rate was assumed but an 83.8% was observed, suggesting that the experimental group did not fulfil the protocol assumptions. Accordingly, the trial suggests that, although the CA time was statistically shortened (9&#x02009;min) in the hybrid group this difference had no effect on measures of myocardial injury including the selected composite as well as the release of cTnT and markers of metabolic stress.</p><p>The trial confirms that the hybrid procedure is surgically feasible and reproducible; 12 surgeons participated across the 3 centres and there was only 1 (1.2%) cross-over from hybrid to conventional surgery. It also suggests that the hybrid procedure is safe; health outcomes were similar to the conventional technique overall and across the 3 centres, although the incidence of mortality was higher in the Indian centres (15.2%) compared to the UK centre (4.9%), probably reflecting the geographical differences in patient characteristics, health outcome, and service provision. The health outcome of the Bristol centre is in keeping with current North American and European standards populations [<xref rid="ezx087-B23" ref-type="bibr">23</xref>, <xref rid="ezx087-B24" ref-type="bibr">24</xref>].</p><p>Shortening of CA time by 9&#x02009;min was insufficient to demonstrate a clinical benefit. The saving of only 9&#x02009;min was probably triggered by a high proportion of single or double-vessel coronary disease recruited (74%), leading to 78% of patients receiving 1 or 2 bypass grafts. Indeed, the amount of CA time saved increased with the number of bypass grafts performed (difference in geometric means 6, 15 and 26&#x02009;min for operations involving 1, 2 and 3 or more bypass grafts, respectively), but no subanalysis was undertaken to assess if longer CA time savings were associated with myocardial injury in keeping with the predefined statistical analysis plan.</p><p>The concept of shortening CA time to minimize myocardial injury is not new. Perrault <italic>et al.</italic> [<xref rid="ezx087-B25" ref-type="bibr">25</xref>] suggested that on-pump beating heart coronary revascularization in patients with poor-left ventricular function and acute myocardial ischaemia eliminated CA related myocardial ischaemia and its negative consequences. However, in a randomized controlled trial in 80 patients randomized to conventional versus on-pump beating heart coronary surgery, we showed comparable results [<xref rid="ezx087-B22" ref-type="bibr">22</xref>].</p><p>The use of on-pump beating heart coronary surgery in patients with valve disease has been reported only in anecdotal studies [<xref rid="ezx087-B26" ref-type="bibr">26</xref>, <xref rid="ezx087-B27" ref-type="bibr">27</xref>]. Our trial provides information that is not subject to the selection bias typical of retrospective, small observational studies.</p><p>The impact of the hybrid procedure on the clinical components of the composite end-point suggests that this was a negative trial. We selected these components due to their direct relation with myocardial injury. This is in keeping with the evidence by others suggesting that a CA time&#x02009;&#x0003e;75&#x02009;min is associated with a higher risk of cardiac death and major adverse cardiac events and that high levels of cTnT are associated with major adverse cardiac events [<xref rid="ezx087-B24" ref-type="bibr">24</xref>, <xref rid="ezx087-B28" ref-type="bibr">28</xref>]. The negative outcome of the trial and the validity of the selected composite are confirmed beyond any doubt by the direct measures of myocardial injury we used, which also did not show differences and included release of cTnT and markers myocardial metabolic stress. cTnT release in the hybrid group confirmed that 9&#x02009;min only of CA time saving is not sufficient to reduce myocardial injury in keeping with the lack of difference in levels of ATP, lactate and adenosine triphosphate (ATD)/adenosine diphosphate ratio in myocardial biopsies.</p><p>In both groups, the median CA time was higher than the critical threshold of 75&#x02009;min suggested by Liakopoulos <italic>et al.</italic> [<xref rid="ezx087-B28" ref-type="bibr">28</xref>]. Of note, Nesher <italic>et al.</italic> [<xref rid="ezx087-B24" ref-type="bibr">24</xref>] suggest a strong association between levels of cTnT exceeding 1.3&#x02009;&#x003bc;g/l and major adverse cardiac events. Our data support this observation as the geometric mean of the maximum cTnT release was 1024&#x02009;ng/l for those who experienced the primary outcome and 769&#x02009;ng/l for those who did not.</p><p>The study has limitations. There were some protocol deviations and 5 randomized patients were excluded from the analysis population. Including all valve pathologies provided an inclusive but potentially heterogeneous population. Follow-up was also limited and quality of life was not assessed. In addition, it may be argued that the 5 components of the composite differ in quantitative clinical importance i.e. a death or a large MI impact more negatively than an arrhythmic event or need for inotropes or for pacing. However, these components were selected as they are all qualitatively clinical reflections of myocardial injury, regardless of their quantitative impact.</p></sec><sec><title>CONCLUSION</title><p>The hybrid procedure was surgically feasible, reproducible and safe. The statistically significant reduction in CA time of 9&#x02009;min was not clinically meaningful as clinical and biochemical measures of myocardial injury were similar between groups. The hybrid procedure is not superior to conventional technique.</p></sec><sec sec-type="supplementary-material"><title>SUPPLEMENTARY MATERIAL</title><p>
<xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref> is available at <italic>EJCTS</italic> online.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sup1"><label>Supplementary Data</label><media xlink:href="ezx087_supp.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We thank all the patients, research nurses and trial coordinators at the 3 participating centres.</p><sec><title>Funding</title><p>This trial was supported by the National Institute for Health Research (NIHR) Bristol Cardiovascular Biomedical Research Unit (BRU), the British Heart Foundation (BHF) and the Garfield Weston Trust. The views and opinions expressed are those of the authors and do not necessarily reflect those of the NIHR, BHF, the UK NHS or the Department of Health.</p><p>
<bold>Conflict of interest:</bold> none declared.</p></sec></ack><ref-list><title>REFERENCES</title><ref id="ezx087-B1"><label>1</label><mixed-citation publication-type="other">
<person-group person-group-type="author"><name name-style="western"><surname>Bridgewater</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Keogh</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kinsman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Walton</surname><given-names>P.</given-names></name></person-group>
<collab>Sixth National Adult Cardiac Surgical Database Report</collab>, <year>2008</year>
<ext-link ext-link-type="uri" xlink:href="http://www.scts.org/_userfiles/resources/SixthNACDreport2008withcovers.org">http://www.scts.org/_userfiles/resources/SixthNACDreport2008withcovers.org</ext-link>.</mixed-citation></ref><ref id="ezx087-B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Buth</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Gainer</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Legare</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Hirsch</surname><given-names>GM.</given-names></name></person-group>
<article-title>The changing face of cardiac surgery: practice patterns and outcomes 2001-2010</article-title>. <source>Can J Cardiol</source><year>2014</year>;<volume>30</volume>:<fpage>224</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">24373760</pub-id></mixed-citation></ref><ref id="ezx087-B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hickey</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Bhabra</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pagano</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McAllister</surname><given-names>K</given-names></name></person-group>
<etal/>
<article-title>Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models</article-title>. <source>Eur J Cardiothorac Surg</source><year>2013</year>;<volume>43</volume>:<fpage>1146</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">23152436</pub-id></mixed-citation></ref><ref id="ezx087-B4"><label>4</label><mixed-citation publication-type="other">
<person-group person-group-type="author"><name name-style="western"><surname>Keogh</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kinsman</surname><given-names>R.</given-names></name></person-group>
<article-title>National Adult Cardiac Surgical Database 1999&#x02013;2000</article-title>. <source>Dendrite Clinical Systems/ The Society of Cardiothoracic Surgeons of Great Britain and Ireland</source>, <year>2003</year>.</mixed-citation></ref><ref id="ezx087-B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Coombs</surname><given-names>LP</given-names></name>, <name name-style="western"><surname>DeLong</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Jamieson</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Shroyer</surname><given-names>ALW</given-names></name></person-group>
<etal/>
<article-title>Prediction of operative mortality after valve replacement surgery</article-title>. <source>JACC</source><year>2001</year>;<volume>37</volume>:<fpage>885</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">11693766</pub-id></mixed-citation></ref><ref id="ezx087-B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Roques</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nashef</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>P</given-names></name></person-group>; <collab>Euro SPG</collab>. 
<article-title>Regional differences in surgical heart valve disease in Europe: comparison between northern and southern subsets of the EuroSCORE database</article-title>. <source>J Heart Valve Dis</source><year>2003</year>;<volume>12</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">12578327</pub-id></mixed-citation></ref><ref id="ezx087-B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ascione</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Caputo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Lotto</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Bryan</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>GD</given-names></name></person-group>
<etal/>
<article-title>Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia</article-title>. <source>Eur J Cardiothorac Surg</source><year>2002</year>;<volume>21</volume>:<fpage>440</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">11888760</pub-id></mixed-citation></ref><ref id="ezx087-B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suleiman</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Halestrap</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Griffiths</surname><given-names>EJ.</given-names></name></person-group>
<article-title>Mitochondria: a target for myocardial protection</article-title>. <source>Pharmacol Ther</source><year>2001</year>;<volume>89</volume>:<fpage>29</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">11316512</pub-id></mixed-citation></ref><ref id="ezx087-B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Maganti</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Borger</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Ivanov</surname><given-names>J</given-names></name>, <name name-style="western"><surname>David</surname><given-names>TE.</given-names></name></person-group>
<article-title>Predictors of low cardiac output syndrome after isolated aortic valve surgery</article-title>. <source>Circulation</source><year>2005</year>;<volume>112</volume>:<fpage>I448</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">16159861</pub-id></mixed-citation></ref><ref id="ezx087-B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Moussa</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lombardi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Salerno</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Ricci</surname><given-names>M.</given-names></name></person-group>
<article-title>The role of beating heart coronary artery bypass grafting in the current era: a point of view</article-title>. <source>J Cardiovasc Surg</source><year>2004</year>;<volume>45</volume>:<fpage>249</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">15179337</pub-id></mixed-citation></ref><ref id="ezx087-B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>YZ</given-names></name>, <name name-style="western"><surname>Spitznagel</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gohlke</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Unger</surname><given-names>T.</given-names></name></person-group>
<article-title>Substrate metabolism, hormone interaction, and angiotensin-converting enzyme inhibitors in left ventricular hypertrophy</article-title>. <source>Diabetes</source><year>1996</year>;<volume>45</volume>:<fpage>S59</fpage>&#x02013;<lpage>65</lpage>.</mixed-citation></ref><ref id="ezx087-B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mehta</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Bruckman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Russman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Karavite</surname><given-names>D</given-names></name></person-group>
<etal/>
<article-title>Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery</article-title>. <source>J Thorac Cardiovasc Surg</source><year>2001</year>;<volume>122</volume>:<fpage>919</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">11689797</pub-id></mixed-citation></ref><ref id="ezx087-B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>McAinsh</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>O'Hare</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nithythyananthan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>O'Gorman</surname><given-names>DJ</given-names></name></person-group>
<etal/>
<article-title>Cardiac hypertrophy impairs recovery from ischaemia because there is a reduced reactive hyperaemic response</article-title>. <source>Cardiovasc Res</source><year>1995</year>;<volume>30</volume>:<fpage>113</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">7553713</pub-id></mixed-citation></ref><ref id="ezx087-B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schonekess</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Allard</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Lopaschuk</surname><given-names>GD.</given-names></name></person-group>
<article-title>Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat hearts</article-title>. <source>Am J Physiol</source><year>1996</year>;<volume>271</volume>:<fpage>H798</fpage>&#x02013;<lpage>805</lpage>.<pub-id pub-id-type="pmid">8770125</pub-id></mixed-citation></ref><ref id="ezx087-B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Buenaventura</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cao-Danh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Glynn</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Simplaceanu</surname><given-names>E</given-names></name>, <name name-style="western"><surname>McGowan</surname><given-names>FX</given-names></name></person-group>
<etal/>
<article-title>Improved protection of the hypertrophied left ventricle by histidine-containing cardioplegia</article-title>. <source>Circulation</source><year>1995</year>;<volume>92</volume>:<fpage>II395</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">7586444</pub-id></mixed-citation></ref><ref id="ezx087-B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suleiman</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Caputo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ascione</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bryan</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Lucchetti</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>WJ</given-names></name></person-group>
<etal/>
<article-title>Metabolic differences between hearts of patients with aortic valve disease and hearts of patients with ischaemic disease</article-title>. <source>J Mol Cell Cardiol</source><year>1998</year>;<volume>30</volume>:<fpage>2519</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">9925386</pub-id></mixed-citation></ref><ref id="ezx087-B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ascione</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lloyd</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Caputo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bryan</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>GD.</given-names></name></person-group>
<article-title>Beating versus arrested heart revascularization: evaluation of myocardial function in a prospective randomized study</article-title>. <source>Eur J Cardiothorac Surg</source><year>1999</year>;<volume>15</volume>:<fpage>685</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">10386418</pub-id></mixed-citation></ref><ref id="ezx087-B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Angelini</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Ascione</surname><given-names>R.</given-names></name></person-group>
<article-title>Early and midterm outcome after off-pump and on-pump surgery in Beating Heart against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials</article-title>. <source>Lancet</source><year>2002</year>;<volume>359</volume>:<fpage>1194</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">11955537</pub-id></mixed-citation></ref><ref id="ezx087-B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ascione</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Caputo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Calori</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lloyd</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Underwood</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>GD.</given-names></name></person-group>
<article-title>Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study</article-title>. <source>Circulation</source><year>2000</year>;<volume>102</volume>:<fpage>1530</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">11004144</pub-id></mixed-citation></ref><ref id="ezx087-B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ascione</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lloyd</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Underwood</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Lotto</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Pitsis</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>GD.</given-names></name></person-group>
<article-title>Inflammatory response after coronary revascularization with or without cardiopulmonary bypass</article-title>. <source>Ann Thorac Surg</source><year>2000</year>;<volume>69</volume>:<fpage>1198</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">10800819</pub-id></mixed-citation></ref><ref id="ezx087-B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ascione</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Rees</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>GD.</given-names></name></person-group>
<article-title>Effectiveness of coronary artery bypass grafting with or without cardiopulmonary bypass in overweight patients</article-title>. <source>Circulation</source><year>2002</year>;<volume>106</volume>:<fpage>1764</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">12356627</pub-id></mixed-citation></ref><ref id="ezx087-B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Narayan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Bayliss</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Rahaman</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Panayiotou</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>GD</given-names></name></person-group>
<etal/>
<article-title>On-pump coronary surgery with and without cardioplegic arrest: comparison of inflammation, myocardial, cerebral and renal injury and early and late health outcome in a single-centre randomised controlled trial</article-title>. <source>Eur J Cardiothorac Surg</source><year>2011</year>;<volume>39</volume>:<fpage>675</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">20884221</pub-id></mixed-citation></ref><ref id="ezx087-B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Holzhey</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mohr</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Walther</surname><given-names>T</given-names></name>, <name name-style="western"><surname>M&#x000f6;llmann</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Beckmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>K&#x000f6;tting</surname><given-names>J</given-names></name></person-group>
<etal/>
<article-title>Current results of surgical aortic valve replacement: insights from the german aortic valve registry</article-title>. <source>Ann Thorac Surg</source><year>2016</year>;<volume>101</volume>:<fpage>658</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">26576751</pub-id></mixed-citation></ref><ref id="ezx087-B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nesher</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Alghamdi</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Sever</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Christakis</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Goldman</surname><given-names>BS</given-names></name></person-group>
<etal/>
<article-title>Troponin after cardiac surgery: a predictor or a phenomenon?</article-title>
<source>Ann Thorac Surg</source>
<year>2008</year>;<volume>85</volume>:<fpage>1348</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">18355525</pub-id></mixed-citation></ref><ref id="ezx087-B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perrault</surname><given-names>LP</given-names></name>, <name name-style="western"><surname>Menasche</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Peynet</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Faris</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>de Chaumaray</surname><given-names>T</given-names></name></person-group>
<etal/>
<article-title>On-pump, beating-heart coronary artery operations in high-risk patients: an acceptable trade-off?</article-title>
<source>Ann Thorac Surg</source>
<year>1997</year>;<volume>64</volume>:<fpage>1368</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">9386706</pub-id></mixed-citation></ref><ref id="ezx087-B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ricci</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Macedo</surname><given-names>FI</given-names></name>, <name name-style="western"><surname>Suarez</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Alba</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Salerno</surname><given-names>TA.</given-names></name></person-group>
<article-title>Multiple valve surgery with beating heart technique</article-title>. <source>Ann Thorac Surg</source><year>2009</year>;<volume>87</volume>:<fpage>527</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">19161773</pub-id></mixed-citation></ref><ref id="ezx087-B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Prifti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bonacchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Giunti</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Frati</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Leacche</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bartolozzi</surname><given-names>F.</given-names></name></person-group>
<article-title>Beating heart ischemic mitral valve repair and coronary revascularization in patients with impaired left ventricular function</article-title>. <source>J Cardiac Surg</source><year>2003</year>;<volume>18</volume>:<fpage>375</fpage>&#x02013;<lpage>83</lpage>.</mixed-citation></ref><ref id="ezx087-B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Liakopoulos</surname><given-names>OJ</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wittwer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Madershahian</surname><given-names>N</given-names></name></person-group>
<etal/>
<article-title>Myocardial protection in cardiac surgery patients requiring prolonged aortic cross-clamp times: a single-center evaluation of clinical outcomes comparing two blood cardioplegic strategies</article-title>. <source>J Cardiovasc Surg</source><year>2010</year>;<volume>51</volume>:<fpage>895</fpage>&#x02013;<lpage>905</lpage>.<pub-id pub-id-type="pmid">21124287</pub-id></mixed-citation></ref></ref-list></back></article>